{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T03:05:20Z","timestamp":1773371120028,"version":"3.50.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T00:00:00Z","timestamp":1766880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T00:00:00Z","timestamp":1766880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20224ACB206007"],"award-info":[{"award-number":["20224ACB206007"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Program of Ganzhou City","award":["2022--RC1341"],"award-info":[{"award-number":["2022--RC1341"]}]},{"name":"Ganpo Talent Support Program - Major Discipline Academic and Technological Leader Training Project","award":["20232BCJ22018"],"award-info":[{"award-number":["20232BCJ22018"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62176114"],"award-info":[{"award-number":["62176114"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103276"],"award-info":[{"award-number":["82103276"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A20390"],"award-info":[{"award-number":["U23A20390"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515010321"],"award-info":[{"award-number":["2023A1515010321"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1245\/s10434-025-18929-8","type":"journal-article","created":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T15:25:51Z","timestamp":1766935551000},"page":"3732-3742","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Deep Learning-Based Multimodal Clinico-Histology-Genomic Prognostic Model in Prostate Cancer"],"prefix":"10.1245","volume":"33","author":[{"given":"Xinyuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bowen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shidong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,28]]},"reference":[{"issue":"3","key":"18929_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin."},{"issue":"1","key":"18929_CR2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","volume":"77","author":"MB Culp","year":"2020","unstructured":"Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A. Recent global patterns in prostate cancer incidence and mortality rates. Eur Urol. 2020;77(1):38\u201352.","journal-title":"Eur Urol."},{"issue":"2","key":"18929_CR3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer\u20142024 update. Part I: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2024;86(2):148\u201363.","journal-title":"Eur Urol."},{"issue":"6","key":"18929_CR4","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1097\/01.ju.0000158155.33890.e7","volume":"173","author":"MR Cooperberg","year":"2005","unstructured":"Cooperberg MR, Pasta DJ, Elkin EP, et al. The UCSF Cancer of the Prostate Risk Assessment (CAPRA) Score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol. 2005;173(6):1938\u201342.","journal-title":"J Urol."},{"issue":"20","key":"18929_CR5","doi-asserted-by":"publisher","first-page":"e183158","DOI":"10.1172\/jci.insight.183158","volume":"9","author":"HE Bergom","year":"2024","unstructured":"Bergom HE, Boytim E, McSweeney S, et al. Androgen production, uptake, and conversion (APUC) genes define prostate cancer patients with distinct clinical outcomes. JCI Insight. 2024;9(20):e183158.","journal-title":"JCI Insight."},{"issue":"1","key":"18929_CR6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1186\/s12967-024-05413-2","volume":"22","author":"M Talia","year":"2024","unstructured":"Talia M, Cesario E, Cirillo F, et al. Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients. J Transl Med. 2024;22(1):597.","journal-title":"J Transl Med."},{"issue":"1","key":"18929_CR7","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1186\/s12964-024-01833-1","volume":"22","author":"M Tabibian","year":"2024","unstructured":"Tabibian M, Moghaddam FS, Motevaseli E, Ghafouri-Fard S. Targeting mRNA-coding genes in prostate cancer using CRISPR\/Cas9 technology with a special focus on androgen receptor signaling. Cell Commun Signal CCS. 2024;22(1):504.","journal-title":"Cell Commun Signal CCS."},{"issue":"6","key":"18929_CR8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1200\/JCO.2017.74.2940","volume":"36","author":"DE Spratt","year":"2018","unstructured":"Spratt DE, Zhang J, Santiago-Jim\u00e9nez M, et al. Development and validation of a novel integrated clinical-genomic risk group classification for localized prostate cancer. J Clin Oncol. 2018;36(6):581\u201390.","journal-title":"J Clin Oncol."},{"issue":"3","key":"18929_CR9","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.eururo.2020.11.021","volume":"79","author":"NK Jairath","year":"2021","unstructured":"Jairath NK, Dal Pra A, Vince R, et al. A systematic review of the evidence for the decipher genomic classifier in prostate cancer. Eur Urol. 2021;79(3):374\u201383.","journal-title":"Eur Urol."},{"issue":"2","key":"18929_CR10","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ijrobp.2023.04.010","volume":"117","author":"DE Spratt","year":"2023","unstructured":"Spratt DE, Liu VYT, Michalski J, et al. Genomic classifier performance in intermediate-risk prostate cancer: results from NRG Oncology\/RTOG 0126 randomized phase 3 trial. Int J Radiat Oncol Biol Phys. 2023;117(2):370\u20137.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"18929_CR11","doi-asserted-by":"publisher","first-page":"950094","DOI":"10.3389\/fonc.2022.950094","volume":"12","author":"A Fan","year":"2022","unstructured":"Fan A, Zhang Y, Cheng J, Li Y, Chen W. A novel prognostic model for prostate cancer based on androgen biosynthetic and catabolic pathways. Front Oncol. 2022;12:950094.","journal-title":"Front Oncol."},{"key":"18929_CR12","doi-asserted-by":"publisher","first-page":"1430565","DOI":"10.3389\/fgene.2024.1430565","volume":"15","author":"G Cheng","year":"2024","unstructured":"Cheng G, Xu J, Wang H, et al. mtPCDI: a machine learning-based prognostic model for prostate cancer recurrence. Front Genet. 2024;15:1430565.","journal-title":"Front Genet."},{"issue":"4","key":"18929_CR13","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1001\/jamaoncol.2020.7671","volume":"7","author":"FY Feng","year":"2021","unstructured":"Feng FY, Huang HC, Spratt DE, et al. Validation of a 22-gene genomic classifier in patients with recurrent prostate cancer. JAMA Oncol. 2021;7(4):544\u201352.","journal-title":"JAMA Oncol."},{"issue":"3","key":"18929_CR14","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.eururo.2014.05.004","volume":"66","author":"EA Klein","year":"2014","unstructured":"Klein EA, Cooperberg MR, Magi-Galluzzi C, et al. A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Eur Urol. 2014;66(3):550\u201360.","journal-title":"Eur Urol."},{"issue":"1","key":"18929_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12967-025-06234-7","volume":"23","author":"K Zhang","year":"2025","unstructured":"Zhang K, Qiu Y, Feng S, et al. Development of model for identifying homologous recombination deficiency (HRD) status of ovarian cancer with deep learning on whole slide images. J Transl Med. 2025;23(1):267.","journal-title":"J Transl Med."},{"issue":"1","key":"18929_CR16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jhep.2022.01.018","volume":"77","author":"Q Zeng","year":"2022","unstructured":"Zeng Q, Klein C, Caruso S, et al. Artificial intelligence predicts immune and inflammatory gene signatures directly from hepatocellular carcinoma histology. J Hepatol. 2022;77(1):116\u201327.","journal-title":"J Hepatol."},{"issue":"1","key":"18929_CR17","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1186\/s12885-024-13248-9","volume":"24","author":"A Ekholm","year":"2024","unstructured":"Ekholm A, Wang Y, Vallon-Christersson J, Boissin C, Rantalainen M. Prediction of gene expression-based breast cancer proliferation scores from histopathology whole slide images using deep learning. BMC Cancer. 2024;24(1):1510.","journal-title":"BMC Cancer."},{"issue":"1","key":"18929_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00428-011-1179-6","volume":"460","author":"H Moch","year":"2012","unstructured":"Moch H, Blank PR, Dietel M, et al. Personalized cancer medicine and the future of pathology. Virchows Arch Int J Pathol. 2012;460(1):3\u20138.","journal-title":"Virchows Arch Int J Pathol."},{"issue":"1","key":"18929_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41596-024-01047-2","volume":"20","author":"OSM El Nahhas","year":"2025","unstructured":"El Nahhas OSM, van Treeck M, W\u00f6lflein G, et al. From whole-slide image to biomarker prediction: end-to-end weakly supervised deep learning in computational pathology. Nat Protoc. 2025;20(1):293\u2013316.","journal-title":"Nat Protoc."},{"issue":"7","key":"18929_CR20","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1109\/TMI.2021.3066295","volume":"40","author":"H Pinckaers","year":"2021","unstructured":"Pinckaers H, Bulten W, van der Laak J, Litjens G. Detection of prostate cancer in whole-slide images through end-to-end training with image-level labels. IEEE Trans Med Imaging. 2021;40(7):1817\u201326.","journal-title":"IEEE Trans Med Imaging."},{"key":"18929_CR21","doi-asserted-by":"publisher","first-page":"102486","DOI":"10.1016\/j.media.2022.102486","volume":"80","author":"W Lu","year":"2022","unstructured":"Lu W, Toss M, Dawood M, Rakha E, Rajpoot N, Minhas F. SlideGraph+: whole slide image level graphs to predict HER2 status in breast cancer. Med Image Anal. 2022;80:102486.","journal-title":"Med Image Anal."},{"issue":"1","key":"18929_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13045-022-01225-3","volume":"15","author":"R Wang","year":"2022","unstructured":"Wang R, Dai W, Gong J, et al. Development of a novel combined nomogram model integrating deep learning-pathomics, radiomics and immunoscore to predict postoperative outcome of colorectal cancer lung metastasis patients. J Hematol Oncol J Hematol Oncol. 2022;15(1):11.","journal-title":"J Hematol Oncol J Hematol Oncol."},{"issue":"5","key":"18929_CR23","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.euo.2024.01.004","volume":"7","author":"AE Ross","year":"2024","unstructured":"Ross AE, Zhang J, Huang HC, et al. External validation of a digital pathology-based multimodal artificial intelligence architecture in the NRG\/RTOG 9902 phase 3 trial. Eur Urol Oncol. 2024;7(5):1024\u201333.","journal-title":"Eur Urol Oncol."},{"key":"18929_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2024.11.009","author":"MC Markowski","year":"2024","unstructured":"Markowski MC, Ren Y, Tierney M, et al. Digital pathology-based artificial intelligence biomarker validation in metastatic prostate cancer. Eur Urol Oncol. 2024. https:\/\/doi.org\/10.1016\/j.euo.2024.11.009.","journal-title":"Eur Urol Oncol."},{"key":"18929_CR25","doi-asserted-by":"publisher","first-page":"110618","DOI":"10.1016\/j.radonc.2024.110618","volume":"202","author":"JH Wang","year":"2025","unstructured":"Wang JH, Deek MP, Mendes AA, et al. Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic castration-sensitive prostate cancer. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2025;202:110618.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol."},{"key":"18929_CR26","doi-asserted-by":"publisher","first-page":"e2400145","DOI":"10.1200\/PO.24.00145","volume":"8","author":"JD Tward","year":"2024","unstructured":"Tward JD, Huang HC, Esteva A, et al. Prostate cancer risk stratification in NRG oncology phase III randomized trials using multimodal deep learning with digital histopathology. JCO Precis Oncol. 2024;8:e2400145.","journal-title":"JCO Precis Oncol."},{"key":"18929_CR27","doi-asserted-by":"publisher","first-page":"e2400653","DOI":"10.1200\/PO-24-00653","volume":"9","author":"FY Feng","year":"2025","unstructured":"Feng FY, Smith MR, Saad F, et al. Digital pathology-based multimodal artificial intelligence scores and outcomes in a randomized phase III trial in men with nonmetastatic castration-resistant prostate cancer. JCO Precis Oncol. 2025;9:e2400653.","journal-title":"JCO Precis Oncol."},{"key":"18929_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41746-022-00613-w","volume":"5","author":"A Esteva","year":"2022","unstructured":"Esteva A, Feng J, van der Wal D, et al. Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials. NPJ Digit Med. 2022;5:71.","journal-title":"NPJ Digit Med."},{"issue":"8","key":"18929_CR29","doi-asserted-by":"publisher","first-page":"e515","DOI":"10.1016\/S2589-7500(23)00095-X","volume":"5","author":"CP Gui","year":"2023","unstructured":"Gui CP, Chen YH, Zhao HW, et al. Multimodal recurrence scoring system for prediction of clear cell renal cell carcinoma outcome: a discovery and validation study. Lancet Digit Health. 2023;5(8):e515\u201324.","journal-title":"Lancet Digit Health."},{"issue":"1","key":"18929_CR30","doi-asserted-by":"publisher","first-page":"6215","DOI":"10.1038\/s41467-024-50369-y","volume":"15","author":"KB Huang","year":"2024","unstructured":"Huang KB, Gui CP, Xu YZ, et al. A multi-classifier system integrated by clinico-histology-genomic analysis for predicting recurrence of papillary renal cell carcinoma. Nat Commun. 2024;15(1):6215.","journal-title":"Nat Commun."},{"issue":"6","key":"18929_CR31","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s10278-013-9622-7","volume":"26","author":"K Clark","year":"2013","unstructured":"Clark K, Vendt B, Smith K, et al. The Cancer Imaging Archive (TCIA): maintaining and operating a public information repository. J Digit Imaging. 2013;26(6):1045\u201357.","journal-title":"J Digit Imaging."},{"issue":"12","key":"18929_CR32","first-page":"1635","volume":"25","author":"CS Zhu","year":"2016","unstructured":"Zhu CS, Huang WY, Pinsky PF, et al. The prostate, lung, colorectal and ovarian cancer (PLCO) screening trial pathology tissue resource. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2016;25(12):1635\u201342.","journal-title":"Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol."},{"issue":"2","key":"18929_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.6004\/jnccn.2021.7065","volume":"20","author":"PT Courtney","year":"2022","unstructured":"Courtney PT, Deka R, Kotha NV, et al. Metastasis and mortality in men with low- and intermediate-risk prostate cancer on active surveillance. J Natl Compr Canc Netw. 2022;20(2):151\u20139.","journal-title":"J Natl Compr Canc Netw."},{"issue":"169","key":"18929_CR34","doi-asserted-by":"publisher","first-page":"169ra10","DOI":"10.1126\/scitranslmed.3005211","volume":"5","author":"MJ Aryee","year":"2013","unstructured":"Aryee MJ, Liu W, Engelmann JC, et al. DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases. Sci Transl Med. 2013;5(169):169ra10.","journal-title":"Sci Transl Med."},{"key":"18929_CR35","doi-asserted-by":"publisher","first-page":"16018","DOI":"10.1038\/srep16018","volume":"5","author":"MM Mortensen","year":"2015","unstructured":"Mortensen MM, H\u00f8yer S, Lynnerup AS, et al. Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy. Sci Rep. 2015;5:16018.","journal-title":"Sci Rep."},{"issue":"1","key":"18929_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","volume":"18","author":"BS Taylor","year":"2010","unstructured":"Taylor BS, Schultz N, Hieronymus H, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010;18(1):11\u201322.","journal-title":"Cancer Cell."},{"key":"18929_CR37","unstructured":"W\u00f6lflein G, Ferber D, Meneghetti AR, et al. Benchmarking pathology feature extractors for whole slide image classification. arXiv. Preprint posted online June 21, 2024."},{"key":"18929_CR38","doi-asserted-by":"publisher","first-page":"102559","DOI":"10.1016\/j.media.2022.102559","volume":"81","author":"X Wang","year":"2022","unstructured":"Wang X, Yang S, Zhang J, et al. Transformer-based unsupervised contrastive learning for histopathological image classification. Med Image Anal. 2022;81:102559.","journal-title":"Med Image Anal."},{"issue":"1","key":"18929_CR39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12874-018-0482-1","volume":"18","author":"JL Katzman","year":"2018","unstructured":"Katzman JL, Shaham U, Cloninger A, Bates J, Jiang T, Kluger Y. DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network. BMC Med Res Methodol. 2018;18(1):24.","journal-title":"BMC Med Res Methodol."},{"issue":"6","key":"18929_CR40","doi-asserted-by":"publisher","first-page":"e205842","DOI":"10.1001\/jamanetworkopen.2020.5842","volume":"3","author":"Y She","year":"2020","unstructured":"She Y, Jin Z, Wu J, et al. Development and validation of a deep learning model for non\u2013small cell lung cancer survival. JAMA Netw Open. 2020;3(6):e205842.","journal-title":"JAMA Netw Open."},{"issue":"11","key":"18929_CR41","doi-asserted-by":"publisher","first-page":"e2025881","DOI":"10.1001\/jamanetworkopen.2020.25881","volume":"3","author":"FM Howard","year":"2020","unstructured":"Howard FM, Kochanny S, Koshy M, Spiotto M, Pearson AT. Machine learning-guided adjuvant treatment of head and neck cancer. JAMA Netw Open. 2020;3(11):e2025881.","journal-title":"JAMA Netw Open."},{"issue":"11","key":"18929_CR42","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1038\/s41596-024-01020-z","volume":"19","author":"S Xu","year":"2024","unstructured":"Xu S, Hu E, Cai Y, et al. Using clusterProfiler to characterize multiomics data. Nat Protoc. 2024;19(11):3292\u2013320.","journal-title":"Nat Protoc."},{"issue":"18","key":"18929_CR43","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1001\/jama.1982.03320430047030","volume":"247","author":"FE Harrell","year":"1982","unstructured":"Harrell FE, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA. 1982;247(18):2543\u20136.","journal-title":"JAMA."},{"key":"18929_CR44","unstructured":"Kang L, Chen W. compareC: Compare two correlated C indices with right-censored survival outcome. Published online May 15, 2025."},{"key":"18929_CR45","doi-asserted-by":"crossref","unstructured":"Zhang J, Jin Z. cutoff: Seek the significant cutoff value. Published online December 20, 2019.","DOI":"10.32614\/CRAN.package.cutoff"},{"issue":"2","key":"18929_CR46","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41391-022-00621-7","volume":"27","author":"H Garg","year":"2024","unstructured":"Garg H, Dursun F, Alsayegh F, et al. Revisiting current National comprehensive cancer network (NCCN) high-risk prostate cancer stratification: a National Cancer Database analysis. Prostate Cancer Prostatic Dis. 2024;27(2):244\u201351.","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"3","key":"18929_CR47","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00345-008-0250-7","volume":"26","author":"MR Cooperberg","year":"2008","unstructured":"Cooperberg MR, Cowan J, Broering JM, Carroll PR. High-risk prostate cancer in the United States, 1990\u20132007. World J Urol. 2008;26(3):211\u20138.","journal-title":"World J Urol."},{"issue":"4","key":"18929_CR48","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41391-020-0226-2","volume":"23","author":"JJ Tosoian","year":"2020","unstructured":"Tosoian JJ, Birer SR, Karnes RJ, et al. Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier. Prostate Cancer Prostatic Dis. 2020;23(4):646\u201353.","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"2","key":"18929_CR49","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41585-020-00400-w","volume":"18","author":"MC Haffner","year":"2021","unstructured":"Haffner MC, Zwart W, Roudier MP, et al. Genomic and phenotypic heterogeneity in prostate cancer. Nat Rev Urol. 2021;18(2):79\u201392.","journal-title":"Nat Rev Urol."},{"issue":"10305","key":"18929_CR50","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S0140-6736(21)00950-8","volume":"398","author":"S Sandhu","year":"2021","unstructured":"Sandhu S, Moore CM, Chiong E, Beltran H, Bristow RG, Williams SG. Prostate cancer. Lancet Lond Engl. 2021;398(10305):1075\u201390.","journal-title":"Lancet Lond Engl."},{"key":"18929_CR51","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.semcancer.2021.11.001","volume":"82","author":"DG Tang","year":"2022","unstructured":"Tang DG. Understanding and targeting prostate cancer cell heterogeneity and plasticity. Semin Cancer Biol. 2022;82:68\u201393.","journal-title":"Semin Cancer Biol."},{"issue":"2","key":"18929_CR52","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41568-021-00408-3","volume":"22","author":"KM Boehm","year":"2022","unstructured":"Boehm KM, Khosravi P, Vanguri R, Gao J, Shah SP. Harnessing multimodal data integration to advance precision oncology. Nat Rev Cancer. 2022;22(2):114\u201326.","journal-title":"Nat Rev Cancer."},{"key":"18929_CR53","doi-asserted-by":"publisher","first-page":"217557","DOI":"10.1016\/j.canlet.2025.217557","volume":"616","author":"H Lin","year":"2025","unstructured":"Lin H, Hua J, Gong Z, et al. Multimodal radiopathological integration for prognosis and prediction of adjuvant chemotherapy benefit in resectable lung adenocarcinoma: a multicentre study. Cancer Lett. 2025;616:217557.","journal-title":"Cancer Lett."},{"issue":"4","key":"18929_CR54","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/annonc\/mdw683","volume":"28","author":"H Tang","year":"2017","unstructured":"Tang H, Wang S, Xiao G, et al. Comprehensive evaluation of published gene expression prognostic signatures for biomarker-based lung cancer clinical studies. Ann Oncol Off J Eur Soc Med Oncol. 2017;28(4):733\u201340.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol."},{"issue":"5","key":"18929_CR55","doi-asserted-by":"publisher","first-page":"bbac294","DOI":"10.1093\/bib\/bbac294","volume":"23","author":"H Huang","year":"2022","unstructured":"Huang H, Zhou G, Liu X, et al. Contrastive learning-based computational histopathology predict differential expression of cancer driver genes. Brief Bioinform. 2022;23(5):bbac294.","journal-title":"Brief Bioinform."},{"issue":"1","key":"18929_CR56","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1038\/s41467-025-57717-6","volume":"16","author":"J Jasti","year":"2025","unstructured":"Jasti J, Zhong H, Panwar V, et al. Histopathology based AI model predicts anti-angiogenic therapy response in renal cancer clinical trial. Nat Commun. 2025;16(1):2610.","journal-title":"Nat Commun."},{"issue":"12","key":"18929_CR57","first-page":"1983","volume":"35","author":"H Farahani","year":"2022","unstructured":"Farahani H, Boschman J, Farnell D, et al. Deep learning-based histotype diagnosis of ovarian carcinoma whole-slide pathology images. Mod Pathol Off J U S Can Acad Pathol Inc. 2022;35(12):1983\u201390.","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"issue":"5","key":"18929_CR58","doi-asserted-by":"publisher","first-page":"e253","DOI":"10.1016\/S1470-2045(19)30154-8","volume":"20","author":"MKK Niazi","year":"2019","unstructured":"Niazi MKK, Parwani AV, Gurcan M. Digital pathology and artificial intelligence. Lancet Oncol. 2019;20(5):e253\u201361.","journal-title":"Lancet Oncol."},{"issue":"10","key":"18929_CR59","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.ccell.2022.09.012","volume":"40","author":"J Lipkova","year":"2022","unstructured":"Lipkova J, Chen RJ, Chen B, et al. Artificial intelligence for multimodal data integration in oncology. Cancer Cell. 2022;40(10):1095\u2013110.","journal-title":"Cancer Cell."},{"issue":"1","key":"18929_CR60","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12943-023-01825-8","volume":"22","author":"J Pencik","year":"2023","unstructured":"Pencik J, Philippe C, Schlederer M, et al. STAT3\/LKB1 controls metastatic prostate cancer by regulating mTORC1\/CREB pathway. Mol Cancer. 2023;22(1):133.","journal-title":"Mol Cancer."},{"issue":"38","key":"18929_CR61","doi-asserted-by":"publisher","first-page":"61890","DOI":"10.18632\/oncotarget.11301","volume":"7","author":"L Ippolito","year":"2016","unstructured":"Ippolito L, Marini A, Cavallini L, et al. Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells. Oncotarget. 2016;7(38):61890\u2013904.","journal-title":"Oncotarget."},{"issue":"5","key":"18929_CR62","doi-asserted-by":"publisher","first-page":"e006581","DOI":"10.1136\/jitc-2022-006581","volume":"11","author":"P Xu","year":"2023","unstructured":"Xu P, Yang JC, Chen B, et al. Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment. J Immunother Cancer. 2023;11(5):e006581.","journal-title":"J Immunother Cancer."},{"issue":"5","key":"18929_CR63","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41419-023-05836-7","volume":"14","author":"YC Wen","year":"2023","unstructured":"Wen YC, Tram VTN, Chen WH, et al. CHRM4\/AKT\/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer. Cell Death Dis. 2023;14(5):304.","journal-title":"Cell Death Dis."},{"key":"18929_CR64","doi-asserted-by":"publisher","first-page":"110663","DOI":"10.1016\/j.cellsig.2023.110663","volume":"107","author":"M Yamaguchi","year":"2023","unstructured":"Yamaguchi M, Hashimoto K, Jijiwa M, Murata T. The inflammatory macrophages repress the growth of bone metastatic human prostate cancer cells via TNF-\u03b1 and IL-6 signaling: involvement of cell signaling regulator regucalcin. Cell Signal. 2023;107:110663.","journal-title":"Cell Signal."},{"issue":"3","key":"18929_CR65","doi-asserted-by":"publisher","first-page":"e230143","DOI":"10.1148\/rycan.230143","volume":"6","author":"C Hu","year":"2024","unstructured":"Hu C, Qiao X, Huang R, Hu C, Bao J, Wang X. Development and validation of a multimodality model based on whole-slide imaging and biparametric MRI for predicting postoperative biochemical recurrence in prostate cancer. Radiol Imaging Cancer. 2024;6(3):e230143.","journal-title":"Radiol Imaging Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18929-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18929-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18929-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:04:27Z","timestamp":1773331467000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18929-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,28]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["18929"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18929-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,28]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}